Carmat
Artificial heart transplant alternative
- B2B
- Publicly traded
- Manufacturing
- Healthtech
- Hardware
- Sales-led purchase
About Carmat
Designs, manufactures, and markets the Aeson artificial heart, a physiological and self-regulated device for end-stage biventricular heart failure patients awaiting transplant.
Key facts
- Industry
- Medical Equipment Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Vélizy-Villacoublay, Île-de-France, France
- Founded
- 2008
- Revenue
- €7.3MFY2024, publicly reported
- Website
- carmatsa.com
- linkedin.com/company/carmat
Carmat at a glance
Carmat is a B2B company in the Medical Equipment Manufacturing industry, headquartered in Vélizy-Villacoublay, Île-de-France, France.
Carmat was founded in 2008.
Carmat has 251–1,000 employees.
Carmat's revenue is €7.3M (FY2024, publicly reported).
Selling to companies like Carmat?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies